Prospective Cohort Study of Combination Therapy With Abemaciclib and Hormonal Therapy for Chemotherapy-Treated Patients With Hormone Receptor-Positive Metastatic Breast Cancer

BACKGROUND: Combination therapy with cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors and hormonal therapy as the first-line and second-line treatments has already been shown to be effective in patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-)...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyahara, Kana, Narui, Kazutaka, Uemura, Yukari, Yamada, Akimitsu, Araki, Kazuhiro, Fujisawa, Fumie, Nakayama, Takahiro, Ishikawa, Takashi, Taira, Naruto, Kikawa, Yuichiro, Aihara, Tomohiko, Mukai, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451572/
https://www.ncbi.nlm.nih.gov/pubmed/36128594
http://dx.doi.org/10.14740/wjon1511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451572/
https://www.ncbi.nlm.nih.gov/pubmed/36128594
http://dx.doi.org/10.14740/wjon1511

Ejemplares similares